April 17, 2018 / 1:01 AM / 8 months ago

BRIEF-Clovis Oncology Announces Pricing Of Public Offerings Of Convertible Senior Notes And Common Stock

April 16 (Reuters) - Clovis Oncology Inc:

* CLOVIS ONCOLOGY ANNOUNCES PRICING OF PUBLIC OFFERINGS OF CONVERTIBLE SENIOR NOTES AND COMMON STOCK

* CLOVIS ONCOLOGY INC- PRICING OF AN UNDERWRITTEN PUBLIC OFFERING OF $300 MILLION AGGREGATE PRINCIPAL AMOUNT OF ITS 1.25% CONVERTIBLE SENIOR NOTES DUE 2025

* CLOVIS ONCOLOGY- ANNOUNCED PRICING OF 1.8 MILLION SHARES OF ITS COMMON STOCK IN AN UNDERWRITTEN PUBLIC OFFERING AT A PRICE TO PUBLIC OF $54.41 PER SHARE

* CLOVIS ONCOLOGY INC - PRICED $300 MILLION AGGREGATE PRINCIPAL AMOUNT OF CONVERTIBLE SENIOR NOTES AT PRICE TO PUBLIC OF 100% OF PRINCIPAL AMOUNT OF NOTES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below